Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone – a case report
Abstract Background Minoxidil solution has routinely been used for decades for the treatment of androgenic alopecia. Central serous chorioretinopathy (CSCR) is a rare side-effect noted following prolonged topical minoxidil therapy for androgenic alopecia. In this report, we describe a case of a 41-y...
Main Authors: | Ramesh Venkatesh, Arpitha Pereira, Kushagra Jain, Naresh Kumar Yadav |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12886-020-01499-6 |
Similar Items
-
Oral Eplerenone Versus Observation in the Management of Acute Central Serous Chorioretinopathy: A Prospective, Randomized Comparative Study
by: Ramesh Venkatesh, et al.
Published: (2020-07-01) -
Oral eplerenone for the management of chronic central serous chorioretinopathy
by: Rishi P Singh, et al.
Published: (2015-04-01) -
Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
by: William J. Anderson, et al.
Published: (2022-12-01) -
Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
by: Hamid-Reza Moein, et al.
Published: (2019-09-01) -
An unusual case of multifocal central serous chorioretinopathy with low serum cortisol managed using eplerenone
by: Kanika Aggarwal, et al.
Published: (2019-01-01)